Open AccessPrednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine
Author(s) -
Fwnm Wit,
Robin Wood,
Andrzéj Horban,
Marek Beniowski,
Reinhold Schmidt,
Glenda Gray,
Adriano Lazzarin,
Alain Lafeuillade,
Débora Paes,
Hilde Carlier,
Liesbeth van Weert,
Corinne De Vries,
Remko van Leeuwen,
Joep M. A. Lange
Publication year - 2001
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-200112070-00010
Subject(s) - abacavir , prednisolone , nevirapine , medicine , regimen , reverse transcriptase inhibitor , odds ratio , gastroenterology , sida , viral load , immunology , human immunodeficiency virus (hiv) , viral disease , antiretroviral therapy
To determine the effect of adjuvant prednisolone use on the development of abacavir (ABC)- and nevirapine (NVP)-associated hypersensitivity reactions (HSR).